We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Embecta Corp (EMBC) USD0.01

Sell:$14.58 Buy:$14.60 Change: $0.48 (3.23%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
Ex-dividend today
Change: $0.48 (3.23%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
Ex-dividend today
Change: $0.48 (3.23%)
Market closed |  Prices as at close on 26 February 2024 | Switch to live prices |
Ex-dividend today
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Embecta Corp. is a global medical device company. The Company is focused on providing solutions to people living with diabetes. The Company has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. The Company also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It distributes its products through a variety of channels, including retail, hospitals, pharmacies and other institutional channels.

Contact details

300 Kimball Drive, Suite 300
NJ 07054
United States
+1 (862) 4010000

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$854.47 million
Shares in issue:
57.58 million
Health Care Supplies
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Devdatt Kurdikar
    President, Chief Executive Officer, Director
  • Jacob Elguicze
    Chief Financial Officer, Senior Vice President
  • Jean Casner
    Chief Human Resource Officer, Senior Vice President
  • Colleen Riley
    Senior Vice President, Chief Technology Officer
  • Jeffrey Mann
    Senior Vice President, General Counsel, Head of Corporate Development, and Corporate Secretary
  • Ginny Blocki
    Senior Vice President - Product Management and Global Marketing
  • Tom Blount
    Senior Vice President and President, North America
  • Shaun Curtis
    Senior Vice President - Global Manufacturing and Supply Chain
  • Brian Capone
    Chief Accounting Officer, Vice President, Corporate Controller
  • Slobodan Radumilo
    Senior Vice President and President - International

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.